Cardlytics (CDLX) Revenue (2017 - 2026)

Cardlytics (CDLX) has reported Revenue for 10 consecutive years, with $36.9 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Revenue fell 36.46% year-over-year to $36.9 million; the trailing twelve-month figure through Jun 2026 stood at $179.3 million (down 29.82% YoY), and the FY2025 full-year result was $233.3 million, down 16.18% from the prior year.
• Revenue climbed to $36.9 million in Q2 2026 per CDLX's latest filing, from $34.3 million in the prior quarter.
• Across five years, Revenue topped out at $89.2 million in Q4 2023 and bottomed at $34.3 million in Q1 2026.
• Historically, Revenue has averaged $65.5 million across 5 years, with a median of $67.8 million in 2022.
• The sharpest annual moves came in 2022 and 2026: Revenue rose 28.12% in 2022, then plunged 39.19% in 2026.
• Over 5 years, Revenue stood at $82.5 million in 2022, then grew by 8.08% to $89.2 million in 2023, then decreased by 17.01% to $74.0 million in 2024, then slipped by 24.19% to $56.1 million in 2025, then plunged by 34.25% to $36.9 million in 2026.
• According to Business Quant data, Revenue over the past three periods registered $36.9 million, $34.3 million, and $56.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.